Copyright Reports & Markets. All rights reserved.

Global Monoclonal Antibody for Multiple Myeloma Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Monoclonal Antibody for Multiple Myeloma Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Elotuzumab
      • 1.4.3 Daratumumab
      • 1.4.4 Siltuximab
      • 1.4.5 Dacetuzumab
      • 1.4.6 Rituximab
      • 1.4.7 Other
    • 1.5 Market by Application
      • 1.5.1 Global Monoclonal Antibody for Multiple Myeloma Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Drug Center
      • 1.5.4 Clinic
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Monoclonal Antibody for Multiple Myeloma Market Size
    • 2.2 Monoclonal Antibody for Multiple Myeloma Growth Trends by Regions
      • 2.2.1 Monoclonal Antibody for Multiple Myeloma Market Size by Regions (2014-2025)
      • 2.2.2 Monoclonal Antibody for Multiple Myeloma Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Monoclonal Antibody for Multiple Myeloma Market Size by by Players
      • 3.1.1 Global Monoclonal Antibody for Multiple Myeloma Revenue by by Players (2014-2019)
      • 3.1.2 Global Monoclonal Antibody for Multiple Myeloma Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Monoclonal Antibody for Multiple Myeloma Market Concentration Ratio (CR5 and HHI)
    • 3.2 Monoclonal Antibody for Multiple Myeloma Key Players Head office and Area Served
    • 3.3 Key Players Monoclonal Antibody for Multiple Myeloma Product/Solution/Service
    • 3.4 Date of Enter into Monoclonal Antibody for Multiple Myeloma Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Monoclonal Antibody for Multiple Myeloma Market Size by Type (2014-2019)
    • 4.2 Global Monoclonal Antibody for Multiple Myeloma Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Monoclonal Antibody for Multiple Myeloma Market Size (2014-2019)
    • 5.2 Monoclonal Antibody for Multiple Myeloma Key Players in United States
    • 5.3 United States Monoclonal Antibody for Multiple Myeloma Market Size by Type
    • 5.4 United States Monoclonal Antibody for Multiple Myeloma Market Size by Application

    6 Europe

    • 6.1 Europe Monoclonal Antibody for Multiple Myeloma Market Size (2014-2019)
    • 6.2 Monoclonal Antibody for Multiple Myeloma Key Players in Europe
    • 6.3 Europe Monoclonal Antibody for Multiple Myeloma Market Size by Type
    • 6.4 Europe Monoclonal Antibody for Multiple Myeloma Market Size by Application

    7 China

    • 7.1 China Monoclonal Antibody for Multiple Myeloma Market Size (2014-2019)
    • 7.2 Monoclonal Antibody for Multiple Myeloma Key Players in China
    • 7.3 China Monoclonal Antibody for Multiple Myeloma Market Size by Type
    • 7.4 China Monoclonal Antibody for Multiple Myeloma Market Size by Application

    8 Japan

    • 8.1 Japan Monoclonal Antibody for Multiple Myeloma Market Size (2014-2019)
    • 8.2 Monoclonal Antibody for Multiple Myeloma Key Players in Japan
    • 8.3 Japan Monoclonal Antibody for Multiple Myeloma Market Size by Type
    • 8.4 Japan Monoclonal Antibody for Multiple Myeloma Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Monoclonal Antibody for Multiple Myeloma Market Size (2014-2019)
    • 9.2 Monoclonal Antibody for Multiple Myeloma Key Players in Southeast Asia
    • 9.3 Southeast Asia Monoclonal Antibody for Multiple Myeloma Market Size by Type
    • 9.4 Southeast Asia Monoclonal Antibody for Multiple Myeloma Market Size by Application

    10 India

    • 10.1 India Monoclonal Antibody for Multiple Myeloma Market Size (2014-2019)
    • 10.2 Monoclonal Antibody for Multiple Myeloma Key Players in India
    • 10.3 India Monoclonal Antibody for Multiple Myeloma Market Size by Type
    • 10.4 India Monoclonal Antibody for Multiple Myeloma Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Monoclonal Antibody for Multiple Myeloma Market Size (2014-2019)
    • 11.2 Monoclonal Antibody for Multiple Myeloma Key Players in Central & South America
    • 11.3 Central & South America Monoclonal Antibody for Multiple Myeloma Market Size by Type
    • 11.4 Central & South America Monoclonal Antibody for Multiple Myeloma Market Size by Application

    12 International Players Profiles

    • 12.1 Bristol Myers Squibb
      • 12.1.1 Bristol Myers Squibb Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Monoclonal Antibody for Multiple Myeloma Introduction
      • 12.1.4 Bristol Myers Squibb Revenue in Monoclonal Antibody for Multiple Myeloma Business (2014-2019)
      • 12.1.5 Bristol Myers Squibb Recent Development
    • 12.2 Abbvie
      • 12.2.1 Abbvie Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Monoclonal Antibody for Multiple Myeloma Introduction
      • 12.2.4 Abbvie Revenue in Monoclonal Antibody for Multiple Myeloma Business (2014-2019)
      • 12.2.5 Abbvie Recent Development
    • 12.3 Janssen Biotech
      • 12.3.1 Janssen Biotech Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Monoclonal Antibody for Multiple Myeloma Introduction
      • 12.3.4 Janssen Biotech Revenue in Monoclonal Antibody for Multiple Myeloma Business (2014-2019)
      • 12.3.5 Janssen Biotech Recent Development
    • 12.4 Karyopharm Therapeutics
      • 12.4.1 Karyopharm Therapeutics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Monoclonal Antibody for Multiple Myeloma Introduction
      • 12.4.4 Karyopharm Therapeutics Revenue in Monoclonal Antibody for Multiple Myeloma Business (2014-2019)
      • 12.4.5 Karyopharm Therapeutics Recent Development
    • 12.5 PDL BioPharma
      • 12.5.1 PDL BioPharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Monoclonal Antibody for Multiple Myeloma Introduction
      • 12.5.4 PDL BioPharma Revenue in Monoclonal Antibody for Multiple Myeloma Business (2014-2019)
      • 12.5.5 PDL BioPharma Recent Development
    • 12.6 Roche
      • 12.6.1 Roche Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Monoclonal Antibody for Multiple Myeloma Introduction
      • 12.6.4 Roche Revenue in Monoclonal Antibody for Multiple Myeloma Business (2014-2019)
      • 12.6.5 Roche Recent Development
    • 12.7 Seattle Genetics
      • 12.7.1 Seattle Genetics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Monoclonal Antibody for Multiple Myeloma Introduction
      • 12.7.4 Seattle Genetics Revenue in Monoclonal Antibody for Multiple Myeloma Business (2014-2019)
      • 12.7.5 Seattle Genetics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Monoclonal Antibody for Multiple Myeloma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Monoclonal Antibody for Multiple Myeloma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Monoclonal Antibody for Multiple Myeloma development in United States, Europe and China.

      The key players covered in this study
      Bristol Myers Squibb
      Abbvie
      Janssen Biotech
      Karyopharm Therapeutics
      PDL BioPharma
      Roche
      Seattle Genetics
      ...

      Market segment by Type, the product can be split into
      Elotuzumab
      Daratumumab
      Siltuximab
      Dacetuzumab
      Rituximab
      Other

      Market segment by Application, split into
      Hospital
      Drug Center
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Monoclonal Antibody for Multiple Myeloma status, future forecast, growth opportunity, key market and key players.
      To present the Monoclonal Antibody for Multiple Myeloma development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Monoclonal Antibody for Multiple Myeloma are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now